Registry study of RefluxStop for GERD patients
Part of Digestive system clinical trials.
This registry study follows people with long-term acid reflux (GERD) who get the RefluxStop treatment. It mainly collects real-world safety and performance information to see how well the device helps over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent and agree to join the registry follow-up.
- You are an adult (18+ or the adult age under local law).
- Your reflux symptoms have been present for more than 6 months.
- You have had a 24-hour reflux test showing abnormal acid/weak-acid reflux while stopping acid-blocking pills (PPIs) for at least 7 days.
- Your doctor believes you can safely undergo laparoscopic surgery under general anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new endoscopic procedure to help people with severe acid reflux that hasn't improved with strong medications. The procedure tightens the valve between the stomach and esophagus to reduce acid backing up.
This trial is testing a device called RefluxStop™ that is implanted during keyhole surgery to treat acid reflux (GERD). The study will check how safe and effective the device is for people with long-term GERD, and it aims to help reduce heartburn and other reflux symptoms.
This study tests a new device called RefluxStop against a standard surgery called Nissen fundoplication to see which better treats long-term acid reflux (GERD). If you have had GERD for at least a year and meet the criteria, you may be able to join.
This is an observational study (no experimental treatment) that follows people who choose a specific procedure called transoral incisionless fundoplication (TIF) with the EsophyX device for long-term acid reflux. It aims to track outcomes for up to 5 years at San Raffaele Hospital.
This study enrolls healthy adults to build a registry and biobank (collection of samples). It tests whether collecting information and biological samples from people without symptoms can help researchers understand normal stomach and esophagus function.
This study checks whether a special test of the esophagus after meals can find the exact reason for ongoing reflux symptoms when proton pump pills (PPIs) don’t help. It may help doctors choose the right next treatment for people whose reflux symptoms keep coming back.
Hear when a new Gastroesophageal Reflux Disease (GERD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.